{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T08:56:30Z","timestamp":1775292990379,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.ejmech.2014.07.066","type":"journal-article","created":{"date-parts":[[2014,7,21]],"date-time":"2014-07-21T13:01:53Z","timestamp":1405947713000},"page":"651-676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Structure and evaluation of antibacterial and antitubercular properties of new basic and heterocyclic 3-formylrifamycin SV derivatives obtained via \u2018click chemistry\u2019 approach"],"prefix":"10.1016","volume":"84","author":[{"given":"Krystian","family":"Pyta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Klich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Domagalska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8072-5877","authenticated-orcid":false,"given":"Piotr","family":"Przybylski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2014.07.066_bib1","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1021\/cr030112j","article-title":"Rifamycin \u2013 mode of action, resistance, and biosynthesis","volume":"105","author":"Floss","year":"2005","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2014.07.066_bib2a","first-page":"146","article-title":"Rifomycin, a new antibiotic; preliminary report","volume":"14","author":"Sensi","year":"1959","journal-title":"Ed. Sci."},{"key":"10.1016\/j.ejmech.2014.07.066_bib2b","first-page":"262","article-title":"Rifomycin. I. Isolation and properties of rifomycin B and rifomycin complex","volume":"7","author":"Sensi","year":"1959","journal-title":"Antibiot. Annu."},{"key":"10.1016\/j.ejmech.2014.07.066_bib3a","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1128\/AAC.01933-12","article-title":"Preliminary pharmacokinetic study of repeated doses of rifampin and rifapentine in guinea pigs","volume":"57","author":"Dutta","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2014.07.066_bib3b","series-title":"Chronicles of Drug Discovery","first-page":"201","article-title":"Rifampicin","author":"Sensi","year":"1982"},{"key":"10.1016\/j.ejmech.2014.07.066_bib4","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0092-8674(01)00286-0","article-title":"Structural mechanism for rifampicin inhibition of bacterial RNA polymerase","volume":"104","author":"Campbell","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2014.07.066_bib5a","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1039\/c2ob00008c","article-title":"Intramolecular proton transfer impact on antibacterial properties of ansamycin antibiotic rifampicin and its new amino analogues","volume":"10","author":"Pyta","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2014.07.066_bib5b","doi-asserted-by":"crossref","first-page":"8283","DOI":"10.1039\/c2ob26317c","article-title":"A\u00a0new model of binding of rifampicin and its amino analogues as zwitterions to bacterial RNA polymerase","volume":"10","author":"Pyta","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2014.07.066_bib6","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1021\/jm4004889","article-title":"X-ray crystal structures of the Escherichia coli RNA polymerase in complex with benzoxazinorifamycins","volume":"56","author":"Molodtsov","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.066_bib7a","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1359-6446(03)02933-7","article-title":"The growing impact of click chemistry on drug discovery","volume":"8","author":"Kolb","year":"2003","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2014.07.066_bib7b","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/cmdc.201000063","article-title":"Azides derived from colchicine and their use in library synthesis: a practical entry to new bioactive derivatives of an old natural drug","volume":"5","author":"Nicolaus","year":"2010","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.066_bib7c","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/13543776.2013.749862","article-title":"Novel 1H-1,2,3-, 2H-1,2,3-, 1H-1,2,4- and 4H-1,2,4-triazole derivatives: a patent review (2008\u20132011)","volume":"23","author":"Ferreira","year":"2013","journal-title":"Expert Opin. Ther. Pat. Engl."},{"key":"10.1016\/j.ejmech.2014.07.066_bib7d","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1002\/asia.201100432","article-title":"Click chemistry: 1,2,3-triazoles as pharmacophores","volume":"6","author":"Agalave","year":"2011","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.ejmech.2014.07.066_bib7e","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejmech.2013.07.011","article-title":"Design, synthesis and biological evaluation of novel mansonone E derivatives prepared via CuAAC click chemistry as topoisomerase II inhibitors","volume":"68","author":"Huang","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.066_bib7f","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ejmech.2012.03.039","article-title":"On the search for potential anti-Trypanosoma cruzi drugs: synthesis and biological evaluation of 2-hydroxy-3-methylamino and 1,2,3-triazolic naphthoquinoidal compounds obtained by click chemistry reactions","volume":"52","author":"da Silva J\u00fanior","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.066_bib7g","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ejmech.2014.01.008","article-title":"Click chemistry approach: regioselective one-pot synthesis of some new 8-trifluoromethylquinoline based 1,2,3-triazoles as potent antimicrobial agents","volume":"74","author":"Garudachari","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.066_bib7h","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ejmech.2013.05.016","article-title":"Dimeric and trimeric triazole based molecules as a new class of Hsp90 molecular chaperone inhibitors","volume":"65","author":"Terracciano","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.066_bib7i","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejmech.2012.12.048","article-title":"Cytotoxicity of lapachol, \u03b2-lapachone and related synthetic 1,4-naphthoquinones against oesophageal cancer cells","volume":"62","author":"Sunassee","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.066_bib7j","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.ejmech.2007.10.015","article-title":"Naphthoquinoidal [1,2,3]-triazole, a new structural moiety active against Trypanosoma cruzi","volume":"43","author":"da Silva","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.066_bib7k","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ejmech.2012.05.014","article-title":"Design and synthesis of a second series of triazole-based compounds as potent dual mPGES-1 and 5-lipoxygenase inhibitors","volume":"54","author":"Chini","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.066_bib7l","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1039\/c3ra46844e","article-title":"Copper-catalyzed one-pot synthesis of glycosylated iminocoumarins and 3-triazolyl-2-iminocoumarins","volume":"4","author":"Mandal","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2014.07.066_bib8","first-page":"357","article-title":"1,3-Dipolar cycloadditions","author":"Huisgen","year":"1961","journal-title":"Proc. Chem. Soc. October"},{"key":"10.1016\/j.ejmech.2014.07.066_bib9a","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1021\/jo011148j","article-title":"Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides","volume":"67","author":"Torn\u00f8e","year":"2002","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2014.07.066_bib9b","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.3762\/bjoc.9.308","article-title":"Advancements in the mechanistic understanding of the copper-catalyzed azide-alkyne cycloaddition","volume":"9","author":"Berg","year":"2013","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.ejmech.2014.07.066_bib9c","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.1021\/ja0749993","article-title":"Ruthenium-catalyzed azide-alkyne cycloaddition: scope and mechanism","volume":"130","author":"Boren","year":"2008","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2014.07.066_bib9d","doi-asserted-by":"crossref","first-page":"14727","DOI":"10.1002\/chem.201103244","article-title":"The first well-defined silver(I)-complex-catalyzed cycloaddition of azides onto terminal alkynes at room temperature,","volume":"17","author":"McNulty","year":"2011","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.ejmech.2014.07.066_bib10a","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1021\/jm00220a009","article-title":"3-N-substituted aminomethyl derivatives of rifamycin SV. A convenient method of synthesis, cyclisation of certain derivatives, and anticellular and antiviral activities of several derivatives","volume":"20","author":"McCarthy","year":"1977","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.066_bib10b","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0040-4020(03)00184-4","article-title":"Rifamycin antibiotics \u2013 new compounds and synthetic methods. Part 1: study of the reaction of 3-formylrifamycin SV with primary alkylamines or ammonia","volume":"59","author":"Bujnowski","year":"2003","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2014.07.066_bib11","series-title":"Scigress Explorer FJ 2.4. (EU 3.1.3.) UserGuide, Fujitsu","year":"2008"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414006813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414006813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T08:53:00Z","timestamp":1538383980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523414006813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":29,"alternative-id":["S0223523414006813"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.07.066","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure and evaluation of antibacterial and antitubercular properties of new basic and heterocyclic 3-formylrifamycin SV derivatives obtained via \u2018click chemistry\u2019 approach","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.07.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}